SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Stenman Ulrika)
 

Sökning: WFRF:(Stenman Ulrika) > Albumin, corticoste...

Albumin, corticosteroid use and Karnofsky performance status predict outcome of single-fraction gamma knife radiosurgery in clear cell renal cell carcinoma patients with brain metastases

Stenman, Maria (författare)
Uppsala universitet,Experimentell och klinisk onkologi,Magnus Lindskog
Benmakhlouf, Hamza (författare)
Department of Medical Radiation Physics and Nuclear Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
Wersäll, Peter (författare)
Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
visa fler...
Hatiboglu, Mustafa Aziz (författare)
Department of Neurosurgery, Bezmialem Vakif University Medical School, Istanbul, Turkey
Silva, Julieta Mayer (författare)
Centro Gamma Knife, CUF Infante Santo Hospital, Lisbon, Portugal
Harmenberg, Ulrika (författare)
Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
Lindskog, Magnus (författare)
Uppsala universitet,Experimentell och klinisk onkologi,Magnus Lindskog
Sinclair, Georges (författare)
Department of Neurosurgery, Bezmialem Vakif University Medical School, Istanbul, Turkey. Department of Neurosurgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
visa färre...
 (creator_code:org_t)
Engelska.
  • Annan publikation (övrigt vetenskapligt/konstnärligt)
Abstract Ämnesord
Stäng  
  • Background and Purpose: To evaluate the effects of single fraction gamma knife radiosurgery (sf-GKRS) on patients with renal cell carcinoma (RCC) brain metastases (BM) in the era of targeted agents (TA).Material and Methods: Clear cell metastatic RCC patients treated with sf-GKRS due to BM in 2005-2014 at three European centres were retrospectively analysed (n=43). Median follow-up was 56 months. Ninety-five percent had prior nephrectomy, 53% synchronous metastasis and 86% extracranial disease at first sf-GKRS. Karnofsky performance status (KPS) ranged from 60-100%.  Outcome measures were overall survival (OS), local control (LC) and adverse radiation effects (ARE).Results: One hundred and ninety-four targets were irradiated. Median number of targets at first sf-GKRS were two. The median prescription dose was 22 Gy. Thirty-seven percent had repeated sf-GKRS. Eighty-eight percent received TA. LC at 12 and 18 months were 97% and 90%. Median OS from first sf-GKRS was 15.7 months. Serum albumin (HR 5.3), corticosteroids pre sf-GKRS (HR 5.8) and KPS (HR 9.1) were independent prognostic factors. MSKCC risk group, synchronous metastasis, age, number of BM or extracranial metastases provided no additional prognostic information. Other prognostic scores for BM radiosurgery, including DS-GPA, Renal-GPA, LLV-SIR and CITV-SIR, did not add prognostic value. ARE were seldom symptomatic and were associated with tumour volume, 10-Gy volume and pre-treatment perifocal oedema. ARE were less common among patients treated with TA within one month of sf-GKRS.Conclusions: We identified three independent prognostic factors with potential impact on clinical decision making in patients with clear cell RCC BM.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

renal cell carcinoma
kidney cancer
stereotactic radiotherapy
stereotactic radiosurgery
radiosurgery
SRS
gamma knife
overall survival
prognostic factors
gkrs
rcc
Oncology
Onkologi

Publikations- och innehållstyp

vet (ämneskategori)
ovr (ämneskategori)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy